The government provides significant new funding to Genomic Medicine Sweden to strengthen precision medicine
The Swedish government announces that it will fund Genomic Medicine Sweden (GMS) with SEK 80 million in 2025. The money will go to continued efforts to develop and sustainably implement precision medicine in healthcare in the areas of cancer, rare diseases and...
Genomic Medicine Sweden receives SEK 49.5 million for precision medicine investments
Today, the Swedish Ministry of Social Affairs announces that it is granting SEK 49.5 million to Genomic Medicine Sweden (GMS) to develop and intensify work in precision diagnostics, childhood cancer, rare diseases and data sharing. “This extensive investment...
Mutation in lung cancer patients linked to increased risk of brain metastases
A population-based study of 6,000 lung cancer patients shows that patients with the KRAS G12C mutation have a high risk of brain metastases. Surprisingly this is not linked to worse survival. The study was conducted by researchers affiliated with Genomic Medicine...
Genomic Medicine Sweden and Danish National Genome Center in partnership to advance precision medicine
Genomic Medicine Sweden and the Danish National Genome Center has signed an agreement with the aim to advance genomics and precision medicine and its implementation in healthcare. The joint partnership will focus on the development and implementation of innovative...